Acute Promyelocytic Leukemia 1st ed. 2018 H XII, 274 p. 39 illus., 29 illus. in color. 18
目次
1 History of APLLaurent Degos 2 Molecular Targets of Treatment in APLRamy Rahmé, Cécile Esnault, Hugues de Thé3 The Leukemic Stem CellThalia Vlachou, Giulia De Conti, Anna Giulia Sanarico, Pier Giuseppe Pelicci4 The Molecular Genetics of APLLourdes Mendez, Ming Chen, Pier Paolo Pandolfi5 APL CoagulopathyAnna Falanga, Laura Russo, Pau Montesinos6 Early Death in APLSören Lehmann7 Prognostic Factors in APLJavier de la Serna, Pau Montesinos, Miguel A. Sanz8 First-line therapy for APL: Chemotherapy-based approach Aaron D. Goldberg, Martin S. Tallman9 First-line Therapy: ATRA-ATO/Reduced Chemotherapy ApproachHarry Iland10 Cure of APL without ChemotherapyMary-Elizabeth M. Percival, Elihu H. Estey11 Minimal Residual Disease in APLLaura Cicconi, Eva Barragàn12 Treatment of refractory and relapsed APLEva Lengfelder13 Hematopoietic Stem Cell Transplantation in APLJaime Sanz, Miguel A. Sanz14 APL in ChildrenMatthew A. Kutny, Anna Maria Testi15 Management of APL in the ElderlyRamy Rahmé, Lionel Adès, Pierre Fenaux16 Special Situations in APLMassimo Breccia, Gloria Iacoboni, Miguel A. Sanz17 APL in Developing Countries: A Chemotherapy-Based ApproachLuisa Corrêa de Araújo Koury, Raul Ribeiro, Eduardo M. Rego18 APL in Developing Countries: ATO based ApproachVikram Mathews19 Therapy-Related APLKristen Pettit, Richard A. Larson20 Rare Acute Leukemia Variants involving Retinoic Acid Receptor GenesLaura Cicconi, Oussama Abla21 Management of Treatment-Related Complications in APLOmbretta Annibali, Giuseppe Avvisati
カート
カートに商品は入っていません。